Abstract
AimsO(6)-methylguanine-DNA-methyltransferase (MGMT) promoter methylation is a high predictive factor for therapy results of temozolomide in patients with glioma. The objective of this work was to analyse the impact of MGMT...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have